Innovative Drugs: China Gains Deals, But Financing Amounts Drop

China has seen a “milestone year for the overseas launch of domestically produced innovative drugs.”

Financing amounts drop
Financing amounts drop • Source: Shutterstock

The Chinese innovative drug market was valued at CNY709.7bn ($97.7bn) in 2023 and is expected to hit CNY753.4bn in 2024 due to the influence of medical insurance adjustments and increased R&D expenditures of pharmaceutical companies.

China ranks second in R&D expenditure on innovative drugs in the world and relies on the industrial advantages of "low...

More from Innovation

More from In Vivo